SCHEMBL29515378

SCHEMBL29515378

Cc1cccc(C)c1-c1nc(NS(=O)(=O)c2cccc(C(=O)O)c2)nc(Cl)c1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ PTK2B Q14289 1/20 0.47
▸ CASP3 P42574 1/20 0.45
▸ SENP8 Q96LD8 1/20 0.45
▸ SENP7 Q9BQF6 1/20 0.45
▸ SENP6 Q9GZR1 1/20 0.45
▸ AKR1C3 P42330 4/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ CA1 P00915 2/20 0.44
▸ CA2 P00918 2/20 0.44
▸ THRB P10828 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ ACLY P53396 1/20 0.42
▸ F2 P00734 1/20 0.41
▸ PRSS1 P07477 1/20 0.41
▸ PRSS2 P07478 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24330983 1.00 KDM4E (0.47) KDM4ETSHRPTK2BCASP3SENP8
SCHEMBL24330985 0.90 SLC40A1 (0.49) KMT2AALDH1A1CA1CA2MEN1
SCHEMBL29515423 0.90 SLC40A1 (0.49) KMT2AALDH1A1CA1CA2MEN1
SCHEMBL24330440 0.90 KDM4E (0.49) KDM4ETSHRPTK2BCASP3SENP8
SCHEMBL24331099 0.88 KDM4E (0.47) KDM4ETSHRPTK2BCASP3SENP8
SCHEMBL29515300 0.88 KDM4E (0.47) KDM4ETSHRPTK2BCASP3SENP8
SCHEMBL24330468 0.87 KDM4E (0.45) KDM4ETSHRPTK2BCASP3SENP8
SCHEMBL29515419 0.87 KDM4E (0.47) KDM4ETSHRPTK2BCASP3SENP8
SCHEMBL24331081 0.87 KDM4E (0.47) KDM4ETSHRPTK2BCASP3SENP8
SCHEMBL24332218 0.86 TSHR (0.46) KDM4ETSHRPTK2BCASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025076235-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-04-10 — — WO disclosed
EP-4225761-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076620-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback